Is a complete CADL research report available?

No complete published report is available for Candel Therapeutics, Inc. (CADL) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Candel Therapeutics, Inc. (CADL)

NASDAQ: CADL · USD

$9.86

-0.23 (-2.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CADL analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	722.4M
Net income (ttm)	-54.4M
EPS (ttm)	-$0.97
Shares out	73.3M
Volume	766,380
Beta	-0.51
Price target	$20.5	+107.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -54.4M
EPS (ttm): -$0.97
Market cap: 722.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CADL indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001841387
Company name	Candel Therapeutics, Inc.
Country	United States
Country code	US
Cusip	137404109
Employees	55
Employees Change	17%
Employees Change Percent	44.74
Enterprise value	$576.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-27
Isin	US1374041093
Last refreshed	2026-07-24
Market cap	$722.4M
Market cap category	Small-Cap
Price	$9.86
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2836
Symbol	CADL
Website	https://www.candeltx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.53%
FCF yield	-6.78%
P/B ratio	5.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-54.4M
Net Income Growth Years	1%
Profit Per Employee	$-989,491
ROA	-23.64
Roa5y	-29.05
ROCE	-28.95
ROE	-51.17
Roe5y	-88.77
ROIC	-25.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	47.87%
Cagr3y	99.03%
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$201.9M
Cash	$194.8M
Current Assets	$197.8M
Current Liabilities	$7.1M
Debt	$49.3M
Debt Equity	$0.36
Equity	$138M
Interest Coverage	-16.71
Liabilities	$63.9M
Long Term Assets	$4.2M
Long Term Liabilities	$56.8M
Net Cash	$145.6M
Net Cash By Market Cap	$20.15
Net Cash Growth	79.15%
Net Debt Equity	$-1.05
Tangible Book Value	$138M
Tangible Book Value Per Share	$1.88
WACC	1.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	28.05
Net Working Capital	$-3.7M
Quick ratio	27.63
Working Capital	$190.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-51.17%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	47.83%
200-day SMA	6.43
3Y total return	688.8%
50-day SMA	9.01
50-day SMA vs 200-day SMA	50over200
All Time High	14.78
All Time High Change	-33.29%
All Time High Date	2021-09-08
All Time Low	0.66
All Time Low Change	1,393.94%
All Time Low Date	2023-11-03
ATR	0.62
Beta	-0.51
Beta1y	0.98
Beta2y	1.22
Ch YTD	74.51
High	10.17
High52	11.36
High52 Date	2026-06-30
High52ch	-13.2%
Low	9.82
Low52	4.35
Low52 Date	2025-11-25
Low52ch	126.67%
Ma50ch	9.48%
Premarket Change Percent	-0.69
Premarket Price	$10.02
Premarket Volume	351
Price vs 200-day SMA	53.42%
RSI	54.5
RSI Monthly	63.41
RSI Weekly	69.34
Sharpe ratio	0.84x
Sortino ratio	1.43
Total Return	-51.17%
Tr YTD	74.51
Tr1m	7.76%
Tr1w	4.01%
Tr3m	34.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	5
Analyst Price Target Top	$19.2
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.25
Operating Income	$-56.3M
Price target	$20.5
Price Target Change	$108
Price Target Change Top	$94.73

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	56,808,480%
Float Percent	77.53%
Net Borrowing	38,713,000
Shares Insiders	8.12%
Shares Institutions	53.33%
Shares Out	73,270,239
Shares Qo Q	13.6%
Shares Yo Y	51.17%
Short Float	28.4%
Short Ratio	7.19
Short Shares	22.02

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-53.9M
Average Volume	1,621,707.35x
Bv Per Share	1.88
CAPEX	$-1.3M
Ch1m	7.76
Ch1w	4.01
Ch1y	47.83
Ch3m	34.33
Ch3y	688.8
Ch6m	56.51
Change	-2.28%
Change From Open	-0.5
Close	10.09
Days Gap	-1.78
Depreciation Amortization	749,000
Dollar Volume	7,556,506.8
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-56.4M
EBITDA	$-55.7M
EPS	$-0.97
F Score	2
FCF	$-49M
FCF EV Yield	-8.49x
FCF Per Share	$-0.67
Financing CF	151,783,000
Fiscal Year End	December
Founded	1,999
Investing CF	-1,232,000
Ipr	23.25
Iprfo	23.25
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	6.81
Ma150ch	44.85%
Ma20	9.87
Ma20ch	-0.06%
Net CF	102,819,000
Next Earnings Date	2026-08-13
Open	9.91
Optionable	Yes
Position In Range	11.43
Post Close	9.86
Postmarket Change Percent	-0.1
Postmarket Price	$9.85
Ppne	3,644,000
Pre Close	10.09
Price Date	2026-07-23
Ptbv Ratio	5.23
Relative Volume	0.47x
Share Based Comp	4,955,000
Tr6m	56.51%
Us State	Massachusetts
Volume	766,380

Candel Therapeutics, Inc. (CADL)

Coverage state: Market snapshot only — no published research

Generate the first CADL analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CADL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CADL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CADL

Frequently asked questions